Skip to main content
. 2020 Jul 1;27(7):644–656. doi: 10.5551/jat.50807

Table 3. Regression analysis for predicting %flow-mediated dilatation improvement.

variable univariate
multivariate
t p-value t p-value
Age −0.119 0.91
Sex 0.892 0.38
Changes in weight −0.154 0.88
Changes in body fat percentage 0.593 0.56
Changes in body muscle percentage 0.919 0.36
Changes in whole body water volume 0.918 0.36
%change plasma volume 0.007 0.99
Changes in hematocrit −0.036 0.97
Changes in urine albumin 1.727 0.09
Changes in e-GFR 0.125 0.90
Changes in uric acid −0.074 0.94
Changes in hemoglobin A1c −2.438 0.02 −1.568 0.12
Changes in 1,5-anhydro-glucitol −0.615 0.54
Changes in fasting plasma glucose −0.214 0.83
Changes in incremental AUC-PG 0.710 0.48
Changes in fasting IRI −2.433 0.02 −1.444 0.16
Changes in incremental AUC-IRI −2.057 0.05
Changes in HOMA-R −1.769 0.08
Changes in LDL cholesterol −1.025 0.31
Changes in HDL cholesterol −0.107 0.92
Changes in fasting triglyceride −5.939 < 0.0001 −5.703 < 0.0001
Changing in incremental AUC-TG −2.112 0.04 −1.667 0.10
Changes in RLP cholesterol −4.971 < 0.0001
Changes in C-reactive protein 0.299 0.77
Changes in BNP 1.618 0.11
Changes in PAI-1 −0.428 0.67
Changing total ketone body 2.057 0.04 1.267 0.21

e-GFR: estimate glomerular filtration rate, AUC-PG: area under the curve of plasma glucose, HOMA-R: homeostasis model assessment insulin resistance, AUC-IRI: area under the curve of immunoreactive insulin, LDL: low density lipoprotein, HDL: high density lipoprotein, AUC-TG; area under the curve of triglyceride, RLP: remnant like particle, BNP: brain natriuretic peptide, PAI-1: plasminogen activator inhibitor-1